Skip to main content
. 2018 Apr 17;2018(4):CD010842. doi: 10.1002/14651858.CD010842.pub2
Methods Randomised controlled trial.
Participants Inclusion criteria: aged ≥ 40 years; documented diagnosis of chronic, stable, primary OA of 1 or both knee joints in association with ≥ 4‐month history of symptomatic knee pain occurring during weight‐bearing activities (people with multiple joint involvement, who had undergone major joint surgery, or had a lower joint prosthesis were also eligible); radiographic evidence of primary OA of 1 or both knee joints, as demonstrated by joint‐space narrowing, marginal spur formation or subchondral cyst formation; use of any of the various common, non‐prescription non‐steroidal anti‐inflammatory drugs ≥ 2 days a week; and non‐participation in a regular programme of physical activity at time of enrolment.
Exclusion criteria: serious medical conditions for which exercise would be contraindicated, such as unstable angina, significant aortic stenosis, myocardial infarction within the last 3 months or advanced chronic obstructive pulmonary disease; asymptomatic primary OA of 1 or both knees; dementia or inability to give informed consent; non‐ambulation due to amputation, stroke or incapacitating arthritis; or involvement in another treatment programme or study protocol.
Country: US.
Sample number: IG: 47; CG: 45.
Mean age: 72 years.
Progress Plus: 75% women; 27% married, 72% unmarried; 96% white American, 3% Hispanic Latino.
Interventions Provider(s): not stated.
Training: yes.
Setting: hospital, group based.
Content: multicomponent: aerobic + patient education.
Length/intensity: 3 sessions a week for 8 weeks.
Control: weekly telephone call.
Outcomes At 12 months:
  • pain (AIMS);

  • self‐efficacy (VAP Self‐Efficacy).

Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Random numbers table.
Allocation concealment (selection bias) High risk Randomisation conducted by the study co‐ordinator; no mention of concealment.
Blinding of participants and personnel (performance bias) All outcomes High risk Participants and providers not blind to treatment allocation.
Blinding of outcome assessment (detection bias) All outcomes High risk Unblinded outcomes assessor.
Incomplete outcome data (attrition bias) All outcomes Unclear risk Attrition: IG: 38.2% (18/47); CG: 48.8% (22/45).
Lost to follow‐up: IG: 3 refused to be interviewed, 2 sick in the hospital and unable to complete an interview, 1 death 1, 12 could not be contacted; CG: 3 refused to be interviewed, 2 death, 17 could not be contacted.
ITT analysis.
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk No other bias detected.